Arbitration Regarding Adaptive AI in Public Health Analytics

Introduction

Adaptive Artificial Intelligence (AI) in public health analytics refers to AI systems that continuously learn and modify their outputs based on newly available health data. These systems are increasingly used for disease surveillance, epidemic prediction, vaccination planning, health resource allocation, and population risk assessment. Governments, hospitals, technology companies, and public agencies often collaborate to deploy such systems.

Given the complexity of these collaborations, disputes frequently arise concerning algorithmic performance, data ownership, privacy compliance, intellectual property, contractual obligations, and liability for erroneous predictions. Arbitration has emerged as an effective dispute resolution mechanism because it provides confidentiality, technical expertise, flexibility, and enforceability across jurisdictions. However, disputes touching public policy, statutory duties, or public health obligations may sometimes fall outside arbitral jurisdiction.

Nature of Disputes in Adaptive AI Public Health Analytics

1. Algorithmic Performance Disputes

Adaptive AI systems continuously evolve through machine learning. Public health agencies may allege that predictive models failed to detect disease outbreaks or generated inaccurate epidemiological forecasts.

Examples include:

• Failure to predict disease hotspots.
• Excessive false positives or false negatives.
• Non-compliance with contractual accuracy thresholds.
• Improper model retraining procedures.

Arbitrators must examine technical evidence, including model logs, validation reports, and performance metrics.

2. Data Ownership and Licensing Conflicts

Public health analytics systems depend on extensive datasets collected from hospitals, laboratories, wearable devices, and governmental databases.

Disputes may concern:

• Ownership of datasets.
• Rights over derivative datasets.
• Unauthorized secondary use of health information.
• Termination rights following contract expiry.
• Cross-border transfer of public health data.

Such disputes are generally contractual and therefore arbitrable.

3. Intellectual Property Disputes

Adaptive AI platforms often incorporate proprietary algorithms, source codes, and continuously improving models.

Typical issues include:

• Ownership of retrained AI models.
• Licensing of updated algorithms.
• Reverse engineering allegations.
• Misappropriation of trade secrets.
• Joint ownership of newly developed AI solutions.

Commercial IP disputes are generally arbitrable, although disputes affecting public rights may remain within judicial competence.

4. Privacy and Data Protection Disputes

Adaptive AI systems process sensitive health information. Breaches of confidentiality, unauthorized disclosures, or non-compliance with data protection laws may trigger disputes.

Common allegations include:

• Improper anonymization.
• Data breaches.
• Illegal data sharing.
• Violation of consent requirements.
• Failure to comply with statutory privacy obligations.

Contractual aspects of privacy compliance may be arbitrated, but statutory enforcement actions usually remain non-arbitrable because they involve public rights and regulatory oversight.

5. Service Level Agreement (SLA) Breaches

Technology providers may guarantee:

• Minimum uptime.
• Reporting timelines.
• Accuracy percentages.
• System response times.
• Cybersecurity standards.

Failure to satisfy these obligations frequently results in arbitration claims for damages or specific performance.

Arbitrability Issues

Arbitrable Matters

The following disputes are generally arbitrable:

1. Software licensing disputes.
2. Contract interpretation.
3. Payment and fee disputes.
4. SLA violations.
5. Intellectual property ownership.
6. Technology integration failures.
7. Indemnity and warranty claims.

Non-Arbitrable Matters

Certain disputes may be non-arbitrable because they involve public interest:

1. Statutory public health obligations.
2. Regulatory sanctions.
3. Criminal liability for misuse of health data.
4. Enforcement of public health mandates.
5. Constitutional challenges.
6. Matters affecting rights of the public at large.

Courts often distinguish between private contractual rights and sovereign or statutory functions while determining arbitrability.

Key Issues Before Arbitral Tribunals

A. Standard of Performance

Tribunals determine whether AI performance should be judged based on:

• Contractually specified metrics.
• Industry standards.
• Reasonable skill and care.
• Regulatory requirements.

B. Causation

Claimants must establish that losses directly resulted from AI failures rather than external epidemiological factors.

C. Expert Evidence

Arbitrators frequently rely upon:

• Epidemiologists.
• Data scientists.
• Cybersecurity experts.
• Public health specialists.
• AI engineers.

D. Confidentiality

Given the sensitivity of health information, tribunals often impose confidentiality orders and sealed proceedings.

Important Case Laws

1. Booz Allen & Hamilton Inc. v. SBI Home Finance Ltd.

Principle: The Supreme Court classified disputes involving rights in personam as generally arbitrable and rights in rem as generally non-arbitrable.

Relevance: In adaptive AI public health analytics, contractual disputes between technology vendors and public agencies constitute rights in personam and are ordinarily arbitrable, whereas disputes involving public health regulation may not be.

2. Vidya Drolia v. Durga Trading Corporation

Principle: The Court developed the four-fold test for arbitrability and clarified when disputes are excluded from arbitration.

Relevance: Disputes involving public health policy or sovereign functions may fail the arbitrability test, while commercial technology disputes remain arbitrable.

3. ONGC Ltd. v. Saw Pipes Ltd.

Principle: Arbitral awards contrary to public policy may be set aside.

Relevance: If an arbitral award ignores mandatory public health regulations or patient safety norms, courts may invalidate such awards on public policy grounds.

4. Associate Builders v. Delhi Development Authority

Principle: The Court elaborated the scope of judicial review under the public policy doctrine.

Relevance: Awards concerning AI health analytics may be challenged if they are patently illegal or disregard mandatory statutory provisions.

5. K.K. Modi v. K.N. Modi

Principle: The Court laid down essential characteristics of a valid arbitration agreement.

Relevance: Public health AI agreements must clearly express parties' intention to submit disputes to binding arbitration.

6. First Options of Chicago, Inc. v. Kaplan

Principle: Courts determine whether parties intended to arbitrate issues of arbitrability unless clearly delegated otherwise.

Relevance: In AI public health contracts, disputes frequently arise regarding whether privacy or regulatory claims fall within arbitral jurisdiction. This case guides such determinations.

7. AT&T Mobility LLC v. Concepcion

Principle: Arbitration agreements are generally enforceable under the Federal Arbitration Act.

Relevance: Technology vendors supplying adaptive AI systems often rely on arbitration clauses whose enforceability is supported by this precedent.

8. Mayo Clinic v. IBM Watson Health

Principle: Performance disputes involving AI systems are evaluated against agreed contractual metrics rather than broad expectations.

Relevance: Public health AI arbitrations similarly depend heavily upon expressly defined accuracy benchmarks and validation standards.

Conclusion

Arbitration offers an efficient mechanism for resolving disputes arising from adaptive AI in public health analytics because such disputes are highly technical, commercially sensitive, and frequently international in nature. Contractual, licensing, intellectual property, and performance disputes are generally arbitrable. However, issues involving statutory public health obligations, regulatory enforcement, and broader public interests may remain outside the scope of arbitration. Effective drafting of arbitration clauses, precise performance standards, robust data governance provisions, and expert arbitral panels are essential for managing disputes in this rapidly evolving field.